Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start" with more than 3,500 healthcare ...

Where early enthusiasm around IDMP programmes had waned in response to slow progress from EMA in Europe towards clarifying ...

Now, in 2025, we expect the life sciences industry will scale its use of GenAI with greater purpose. As these applications ...

The FDA previously designated the ADC as a breakthrough drug for relapsed or refractory extensive-stage small-cell lung ...

According to the US regulator, the use of AI in drug development and in regulatory submissions has "exponentially increased" ...

The result is another major disappointment to ALS patients, who have limited drug treatment options at present, particularly ...

1. Proactively identify barriers to medication adherence, including identifying and targeting patients who may be ...

The unidentified man is one of 66 confirmed human cases of H5N1 bird flu in the US since 2024, when the current outbreak took ...

Fortunately, my home isn't too far from Stamford Bridge stadium, making it easy to catch the action live! Connect with Peter ...

NeOnc has two products in development, namely NEO100 – a purified form of perillyl acid (POH) that is administered to brain ...

The upgraded NHS App, due to be ready in March, will allow almost all patients to contact their GP or hospital for non-urgent ...

That is more than three times higher than last year, but not quite at the same level that was reached in the 2022-2023 flu ...